MICS + trabeculectomy a good match

Article

Microincision cataract surgery (MICS) combined with trabeculectomy provides a one-year intraocular pressure (IOP) control comparable to that found with trabeculectomy and separate temporal clear corneal phaco, according to the results of a study by Dr Bayer and colleagues from the Ankara School of Medicine, Turkey.

Microincision cataract surgery (MICS) combined with trabeculectomy provides a one-year intraocular pressure (IOP) control comparable to that found with trabeculectomy and separate temporal clear corneal phaco, according to the results of a study by Dr Bayer and colleagues from the Ankara School of Medicine, Turkey.

A total of 63 eyes with co-existing cataract and glaucoma were randomly assigned to receive mitomycin-C (MMC) trabeculectomy in the superior quadrant combined with phaco and foldable intraocular lens (IOL) implantation through a separate, temporal, clear corneal incision (2-site group) or MMC trabeculectomy in a superior quadrant combined with MICS followed by IOL implantation from the trabeculectomy incision.

Mean preoperative IOP was 28.1±7.1 mmHg and 27.7±6.5 mmHg in the 2-site and MICS groups, respectively. At six-months postoperatively, mean IOP was 14.9±4.3 and 14.3±3.8 mmHg, respectively (p=0.7) and at 12 months, 15.6±3.3 and 15.1±3.1 mmHg, respectively (p=0.5). Postoperative astigmatic change and complications were comparable between the groups.

Dr Bayer concluded that MICS with trabeculectomy and trabeculectomy with separate temporal clear corneal phaco provide comparable IOP control at one-year.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.